Czerw Aleksandra, Deptała Andrzej, Głowacka Mariola, Partyka Olga, Pajewska Monika, Czerw Natalia, Badowska-Kozakiewicz Anna, Sygit Katarzyna, Kopczyński Zygmunt, Czarnywojtek Piotr, Gąska Izabela, Kaczmarski Mateusz, Banaś Tomasz, Grochans Elżbieta, Grochans Szymon, Cybulska Anna M, Schneider-Matyka Daria, Bandurska Ewa, Ciećko Weronika, Dykowska Grażyna, Sienkiewicz Zofia, Drobnik Jarosław, Pobrotyn Piotr, Grata-Borkowska Urszula, Furtak-Pobrotyn Joanna, Sierocka Aleksandra, Marczak Michał, Pokorna-Kalwak Dagmara, Kozlowski Remigiusz
Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
J Clin Med. 2025 Apr 29;14(9):3067. doi: 10.3390/jcm14093067.
Screening is widely considered one of the most effective methods for the early detection of prostate cancer. Early detection allows for prompt treatment, which increases the likelihood of a full recovery. This review sought to summarize studies on screening methods related to prostate cancer. It examined trends in screening practices and organized the findings into two main categories. The first category focused on strategies to boost screening participation, reach underserved populations, and improve public awareness of health issues. The second category concentrated on refining current diagnostic methods, developing new tests, and testing biomarkers. A significant portion of the research also explored diagnostic techniques aimed at enhancing patient comfort during exams without compromising clinical effectiveness.
J Clin Med. 2025-4-29
Cochrane Database Syst Rev. 2022-2-1
Early Hum Dev. 2020-11
2025-1
Urol Oncol. 2025-1
Int J Mol Sci. 2022-12-29
Urol Clin North Am. 2021-8
J Med Ethics. 2020-7-6